Cargando…
Understanding tolerance to cell wall–active antibiotics
Antibiotic tolerance—the ability of bacteria to survive for an extended time in the presence of bactericidal antibiotics—is an understudied contributor to antibiotic treatment failure. Herein, I review the manifestations, mechanisms, and clinical relevance of tolerance to cell wall–active (CWA) anti...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359209/ https://www.ncbi.nlm.nih.gov/pubmed/33274447 http://dx.doi.org/10.1111/nyas.14541 |
_version_ | 1783737497786777600 |
---|---|
author | Dörr, Tobias |
author_facet | Dörr, Tobias |
author_sort | Dörr, Tobias |
collection | PubMed |
description | Antibiotic tolerance—the ability of bacteria to survive for an extended time in the presence of bactericidal antibiotics—is an understudied contributor to antibiotic treatment failure. Herein, I review the manifestations, mechanisms, and clinical relevance of tolerance to cell wall–active (CWA) antibiotics, one of the most important groups of antibiotics at the forefront of clinical use. I discuss definitions of tolerance and assays for tolerance detection, comprehensively discuss the mechanism of action of β‐lactams and other CWA antibiotics, and then provide an overview of how cells mitigate the potentially lethal effects of CWA antibiotic–induced cell damage to become tolerant. Lastly, I discuss evidence for a role of CWA antibiotic tolerance in clinical antibiotic treatment failure. |
format | Online Article Text |
id | pubmed-8359209 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83592092021-08-17 Understanding tolerance to cell wall–active antibiotics Dörr, Tobias Ann N Y Acad Sci Reviews Antibiotic tolerance—the ability of bacteria to survive for an extended time in the presence of bactericidal antibiotics—is an understudied contributor to antibiotic treatment failure. Herein, I review the manifestations, mechanisms, and clinical relevance of tolerance to cell wall–active (CWA) antibiotics, one of the most important groups of antibiotics at the forefront of clinical use. I discuss definitions of tolerance and assays for tolerance detection, comprehensively discuss the mechanism of action of β‐lactams and other CWA antibiotics, and then provide an overview of how cells mitigate the potentially lethal effects of CWA antibiotic–induced cell damage to become tolerant. Lastly, I discuss evidence for a role of CWA antibiotic tolerance in clinical antibiotic treatment failure. John Wiley and Sons Inc. 2020-12-03 2021-07 /pmc/articles/PMC8359209/ /pubmed/33274447 http://dx.doi.org/10.1111/nyas.14541 Text en © 2020 The Authors. Annals of the New York Academy of Sciences published by Wiley Periodicals LLC on behalf of New York Academy of Sciences https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Dörr, Tobias Understanding tolerance to cell wall–active antibiotics |
title | Understanding tolerance to cell wall–active antibiotics |
title_full | Understanding tolerance to cell wall–active antibiotics |
title_fullStr | Understanding tolerance to cell wall–active antibiotics |
title_full_unstemmed | Understanding tolerance to cell wall–active antibiotics |
title_short | Understanding tolerance to cell wall–active antibiotics |
title_sort | understanding tolerance to cell wall–active antibiotics |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359209/ https://www.ncbi.nlm.nih.gov/pubmed/33274447 http://dx.doi.org/10.1111/nyas.14541 |
work_keys_str_mv | AT dorrtobias understandingtolerancetocellwallactiveantibiotics |